Pharma and Biotech
Appointment of UK Lead Broker and Change of Co Sec | 01-Mar-2023 | 07:02 | RNS |
Half-year Report | 28-Feb-2023 | 09:08 | RNS |
Provision of US$600,000 funding and change of CFO | 03-Feb-2023 | 07:00 | RNS |
Extension of Convertible Securities Agreements | 02-Feb-2023 | 07:00 | RNS |
December 2022 Quarterly Activities and Cash Flow | 30-Jan-2023 | 07:00 | RNS |
Second Price Monitoring Extn | 23-Jan-2023 | 16:40 | RNS |
Price Monitoring Extension | 23-Jan-2023 | 16:35 | RNS |
Change in External Financial Auditor | 11-Jan-2023 | 09:01 | RNS |
Completion of CimetrA™ Pre-clinical Trial | 10-Jan-2023 | 07:00 | RNS |
Internal Costs Review Completed and Board Change | 03-Jan-2023 | 07:00 | RNS |
A$800,000 funding received under Mercer Facility | 28-Dec-2022 | 09:10 | RNS |
Completion of CimetrA Efficacy Pre-clinical Trial | 07-Dec-2022 | 07:00 | RNS |
Delivery of US$1m order of ArtemiC to AMC Holdings | 05-Dec-2022 | 07:00 | RNS |
Publication of MGC Pharma Glioblastoma research | 02-Dec-2022 | 07:00 | RNS |
Result of AGM and Investor Presentation | 28-Nov-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 20.67p |
Change Today | -0.33p |
% Change | -1.59 % |
52 Week High | 550.00 |
52 Week Low | 18.00 |
Volume | 10 |
Shares Issued | 3,286.48m |
Market Cap | £679.21m |
RiskGrade | 1,233 |
Value | ![]() |
---|
Value | ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
11:28 | 5 @ 20.00p |
08:04 | 5 @ 20.00p |
You are here: research